COPD Clinical Trials in Los Angeles

Showing 21-40 of 97 trials

The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 3)

NCT03583099

A prospective, multicenter study including a cross-section validation to define sensitivity and specificity of CAPTURE to identify previously undiagnosed patients with clinically significant Chronic Obstructive Pulmonary Disease (COPD), and its impact on clinical care across a broad range of primary care settings in a cluster randomized controlled clinical trial.

Chronic Obstructive Pulmonary Disease (COPD)

Weill Medical College of Cornell University2,004 participantsStarted Oct 2018

Los Angeles, California, United States • Aurora, Colorado, United States • Miami, Florida, United States +6 more locations

TERMINATEDPhase 3< 1 mile

A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD)

NCT03496623

The primary objective of this study is to demonstrate the efficacy of inhaled treprostinil compared to placebo in improving exercise ability as measured by change from baseline in 6-Minute Walk Distance (6MWD) following 12 weeks of active treatment in participants with PH-COPD.

Pulmonary HypertensionChronic Obstructive Pulmonary Disease

United Therapeutics188 participantsStarted May 2018

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +73 more locations

The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 3)

A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD)

COPD Trials in Other Cities

A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD

A Phase 3 Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD

The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 2)

Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)

A 6-week Dose Ranging Study of CHF 5259 pMDI in Subjects With Chronic Obstructive Pulmonary Disease

A Study to Assess Drug Absorption of Fixed Dose Combinations of Budesonide, Glycopyrronium, and Formoterol

Pulmonary Vascular Changes in Early Chronic Obstructive Pulmonary

Goals of Care Conversations Study

Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap

Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

A Phase 2 Study of MP-376 to Prevent Acute Exacerbations in Chronic Obstructive Pulmonary Disease (COPD) Patients

Observational Study of Obstructive Lung Disease (NOVELTY)

Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD

Extracorporeal CO2 Removal With the Hemolung RAS for Mechanical Ventilation Avoidance During Acute Exacerbation of COPD

A 42-day Parallel Group Safety Study of Revefenacin and Formoterol, Administered in Sequence and as a Combination, in Participants With COPD

An Efficacy and Safety Profile of Inhaled TV48108 in Healthy Volunteers and COPD Patients

Changing the Paradigm of In-Hospital Cardiopulmonary Resuscitation

Communication During Hospitalization About Resuscitation Trial

Other Conditions in Los Angeles